Subjects with prostate cancer are less likely to develop esophageal cancer: Analysis of SEER 9 registries database

Cancer Causes and Control

Volumn 23, Issue 6, 2012, Pages 819-825

  Cooper, S C ^a,b   Trudgill, N J ^a  

^a SANDWELL GENERAL HOSPITAL   (United Kingdom)

^b DUDLEY GROUP OF HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Androgens; Esophageal adenocarcinoma; Esophageal cancer; Esophageal squamous cell carcinoma; Prostate cancer; SEER dataset

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; DISEASE ASSOCIATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ETHNIC DIFFERENCE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RISK REDUCTION; SECOND CANCER; STANDARDIZED INCIDENCE RATIO;

ESOPHAGEAL ADENOCARCINOMA, ESOPHAGEAL CANCER, ESOPHAGEAL SQUAMOUS CELL CARCINOMA, PROSTATE CANCER, ANDROGENS, SEER DATASET;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; HUMANS; INCIDENCE; MALE; NEOPLASMS, SECOND PRIMARY; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RETROSPECTIVE STUDIES; RISK FACTORS; SEER PROGRAM;

EID: 84862497546     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-9950-9     Document Type: Article

References (34)

1. Cooper SC, Day R, Brooks C, Livings C, Thomson CS, Trudgill NJ (2009) The influence of deprivation and ethnicity on the incidence of esophageal cancer in England. Cancer Causes Control 20(8):1459-1467
2. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr (1991) Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265(10):1287-1289
3. Lagergren J, Bergström R, Lindgren A, Nyrén O (1999) Symptomatic gastroesophageal reflux as a risk factor for oesophageal adenocarcinoma. N Engl J Med 340:825-831 (Pubitemid 29142625)
4. Wu AH, Tseng C-C, Bernstein L (2003) Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinomas. Cancer 98:940-948 (Pubitemid 37022093)
5. Lagergren J, Bergström R, Nyrén O (1999) Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 130:883-890 (Pubitemid 29239582)
6. Vaughan TL, Davis S, Kristal AS, Thomas DB (1995) Obesity, alcohol and tobacco as risk factors for cancers of the oesophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomark Prev 4:85-92
7. Engel LS, Chow W-H, Vaughan TL, Gammon MD et al (2003) Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 95:1404-1413 (Pubitemid 37220460)
8. Jansson C, Johansson AL, Bergdahl IA et al (2005) Occupational exposures and risk of esophageal and gastric cardia cancers among male Swedish construction workers. Cancer Causes Control 16(6):755-764 (Pubitemid 41110967)
9. Waraich N, Clarke P, Meckenzie A, Grabowska A, Iftikhar S, Watson S (2008) Androgen receptor expression in the stroma of oesophageal carcinoma. Gut 57(Suppl 1):A131
10. Awan AK, Iftikhar SY, Morris TM et al (2007) Androgen receptors may act in a paracrine manner to regulate oesophageal adenocarcinoma growth. Eur J Surg Oncol 33(5):561-568
11. Tihan T, Harmon JW, Wan X, et al (2001) Evidence of androgen receptor expression in squamous and adenocarcinoma of the esophagus. Anticancer Res 21(4B): 3107-3114 (Pubitemid 33051184)
12. Balk SP, Knudsen KE (2008) AR, the cell cycle, and prostate cancer. Nucl Recept Signal 6:e001
13. Cancer Research UK (2008). CancerStats report - Prostate Cancer UK, Cancer Research UK
14. Cooper SC, Croft S, Day R, Thomson CS, Trudgill NJ (2009) Patients with prostate cancer are less likely to develop oesophageal adenocarcinoma; could anti-androgen therapy have a protective role? Cancer Causes Control 20(8):1363-1368
15. Jones GW (1983) Diagnosis and management of prostate cancer. Cancer 51(12 Suppl):2456-2459
16. Hankey BF, Ries LA, Edwards BK (1999) The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomark Prev 8:1117-1121 (Pubitemid 30004912)
17. Yanke BV, Carver BS, Bianco FJ Jr et al (2006) African- American race is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram. BJU Int 98(4):783-787 (Pubitemid 44368025)
18. Breslow NE, Day NE (1987) Statistical methods in cancer research. Vol II the design and analysis of cohort studies. IARC Scientific Publication No.82, Chapter 2. IARC, Lyon
19. Lagergren J, Nyren O (1998) Do sex hormones play a role in the etiology of esophageal adenocarcinoma? A new hypothesis tested in a population based cohort of prostate cancer patients. Cancer Epidemiol Biomark Prev 7:913-915 (Pubitemid 28471580)
20. Hayat MJ, Hawlader N, Reichman ME, Edwards BK (2007) Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program. Oncologist 12:20-37 (Pubitemid 46143500)
21. Ahsan H, Neugut AI, Gammon MD (1997) Association of adenocarcinoma and squamous cell carcinoma of the esophagus with tobacco-related and other malignancies. Cancer Epidemiol Biomarkers Prev 6(10):779-782 (Pubitemid 27435475)
22. El-Serag HB, Mason AC, Petersen N, Key CR (2002) Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 50:368-372 (Pubitemid 34161053)
23. Rowan S (2007) Trends in cancer incidence by deprivation, England and Wales, 1990-2002. Health Stat Q 36:24-35
24. Brown LM, Hoover R, Silverman D et al (2001) Excess incidence of squamous cell esophageal cancer among US black men: role of social class and other risk factors. Am J Epidem 153(2):114-122 (Pubitemid 32063186)
25. Nguyen AM, Luke CG, Roder D (2003) Comparative epidemiological characteristics of oesophageal adenocarcinoma and other cancers of the oesophagus and gastric cardia. Asian Pacific J Cancer Prev 4:225-231
26. Brown LM, Silverman DT, Pottern LM et al (1994) Adenocarcinoma of the esophagus and esophagogastric junction in white men in the United States: alcohol, tobacco, and socioeconomic factors. Cancer Causes Control 5(4):333-340 (Pubitemid 24205561)
27. Welch HG, Albertsen PC (2009) Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Inst 101(19):1325-1329
28. Shao Y-H, Demissie K, Shih W et al (2009) Contemporary risk profile of prostate cancer in the United States. J Natl Cancer Inst 101(18):1280-1283
29. Brower V (2009) Long- or short-term hormones for locally advanced prostate cancer? J Natl Cancer Inst 101(23):1606-1608
30. Cooperberg MR, Grossfield GD, Lubeck DP, Carroll PR (2003) National practice patterns and time trends in androgen ablation for localized prostate. Cancer 95(13):981-989 (Pubitemid 36896715)
31. Sutton S, Wardle J, Taylor T et al (2000) Predictors of attendance in the United Kingdom flexible sigmoidoscopy screening trial. J Med Screen 7(2):99-104
32. Thomas MC, Walker M, Lennon LT, Thomson AG, Lampe FC, Shaper AG, Whincup PH (2002) Non-attendance at re-examination in the British regional heart study. J Public Health Med 24(4):285-291 (Pubitemid 36043189)
33. Velicer CM, Ulrich CM (2008) Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol 26(4):665-673 (Pubitemid 351264364)
34. Gillessen S, Templeton A, Marra G, Kuo Y-F, Valtorta E, Shahinian VB (2010) Risk of colorectal cancer in men on longterm androgen deprivation therapy for prostate cancer. J Natl Cancer Inst 102(23):1760-1770